UNSPSC 51152404: Aspirin/methocarbamol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class MS200. This VA Drug Class (MS200) classifies this compound as belonging to the group SKELETAL MUSCLE RELAXANTS.

UNSPSC 51152404 Aspirin/methocarbamol is a Commodity code that, based on recent state and local solicitation activity, appears misaligned with actual procurement under this taxonomy entry. The single recent opportunity tagged to this code — Seminole County, Florida's IFB60459723LAS — solicits naloxone and safe drug deactivation systems for community health initiatives, neither of which are aspirin or methocarbamol products. The mismatch suggests either a tagging error in the county's e-procurement system or that this Commodity code is not the operative classification for pharmaceutical procurements state and local governments are currently pursuing under their standard taxonomy.

The Seminole County opportunity (IFB posted June 30, 2026; response deadline July 26, 2026) called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract offered an initial two-year term with a one-year renewal option and required vendors to meet E-Verify compliance, drug-free workplace certification, and specific insurance coverages. Potential FEMA funding introduced Clean Air Act and Federal Water Pollution Control Act compliance obligations. The source shows no additional recent state or local opportunities under this code; activity at this Commodity level appears limited, and the single named opportunity does not track to the code's nominal pharmaceutical scope.